Onco Targets Ther. 2021 Nov 27;14:5335-5344. doi: 10.2147/OTT.S340435. eCollection 2021.
The Controversial Role of Polyploidy in Hepatocellular Carcinoma.
OncoTargets and therapy
Nan Wang, Fengjie Hao, Yan Shi, Junqing Wang
Affiliations
Affiliations
- Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
- Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
PMID: 34866913
PMCID: PMC8636953 DOI: 10.2147/OTT.S340435
Abstract
Polyploidy, a physiological phenomenon in which cells contain more than two sets of homologous chromosomes, commonly exists in plants, fish, and amphibians but is rare in mammals. In humans, polyploid cells are detected commonly in specific organs or tissues including the heart, marrow, and liver. As the largest solid organ in the body, the liver is responsible for a myriad of functions, most of which are closely related to polyploid hepatocytes. It has been confirmed that polyploid hepatocytes are related to liver regeneration, homeostasis, terminal differentiation, and aging. Polyploid hepatocytes accumulate during the aging process as well as in chronically injured livers. The relationship between polyploid hepatocytes and hepatocellular carcinoma, the endpoint of most chronic liver diseases, is not yet fully understood. Recently, accumulated evidence has revealed that polyploid involves in the process of tumorigenesis and development. The study of the correlation and relationship between polyploidy hepatocytes and the development of hepatocellular carcinoma can potentially promote the prevention, early diagnosis, and treatment of hepatocellular carcinoma. In this review, we conclude the potential mechanisms of polyploid hepatocytes formation, focusing on the specific biological significance of polyploid hepatocytes. In addition, we examine recent discoveries that have begun to clarify the relevance between polyploid hepatocytes and hepatocellular carcinoma and discuss recent excellent findings that reveal the role of polyploid hepatocytes as resisters of hepatocellular carcinoma or as promoters of hepatocarcinogenesis.
© 2021 Wang et al.
Keywords: cancer; cell cycle; hepatocyte; liver; polyploidy
Conflict of interest statement
The authors report no conflicts of interest in this work.
References
- J Cell Biochem. 2018 Jul;119(7):6238-6248 - PubMed
- Cell Cycle. 2010 Feb 1;9(3):460-6 - PubMed
- Genes Dev. 2017 Jan 1;31(1):34-45 - PubMed
- Hepatology. 2013 May;57(5):2004-13 - PubMed
- J Clin Invest. 2009 Jul;119(7):1880-7 - PubMed
- J Cell Biol. 2015 May 25;209(4):485-91 - PubMed
- Dev Cell. 2010 Feb 16;18(2):175-89 - PubMed
- Dev Cell. 2018 Feb 26;44(4):447-459.e5 - PubMed
- Cell. 2018 Sep 20;175(1):200-211.e13 - PubMed
- Hepatology. 2016 Aug;64(2):599-615 - PubMed
- Mol Cell. 2017 Aug 3;67(3):400-410.e7 - PubMed
- Am J Pathol. 2014 Feb;184(2):322-31 - PubMed
- Nat Rev Mol Cell Biol. 2014 Mar;15(3):197-210 - PubMed
- Oncogene. 2004 Feb 26;23(8):1489-97 - PubMed
- Gastroenterology. 2012 Jan;142(1):25-8 - PubMed
- Nat Cell Biol. 2012 Nov;14(11):1181-91 - PubMed
- Nat Genet. 2018 Aug;50(8):1189-1195 - PubMed
- Front Physiol. 2017 Oct 31;8:862 - PubMed
- Cell Death Dis. 2017 May 18;8(5):e2805 - PubMed
- Nature. 2009 Jul 9;460(7252):278-82 - PubMed
- Hepatology. 2019 Mar;69(3):1242-1258 - PubMed
- Cancer. 1988 Apr 15;61(8):1555-62 - PubMed
- Science. 1989 Nov 3;246(4930):629-34 - PubMed
- EMBO J. 2011 Jan 19;30(2):355-63 - PubMed
- Clin Cancer Res. 1999 May;5(5):963-70 - PubMed
- Inflamm Res. 2002 Aug;51(8):416-22 - PubMed
- CA Cancer J Clin. 2021 May;71(3):209-249 - PubMed
- J Cell Sci. 2007 Oct 15;120(Pt 20):3633-9 - PubMed
- Gut. 2020 Feb;69(2):355-364 - PubMed
- Gastroenterology. 2018 Apr;154(5):1421-1434 - PubMed
- Dev Cell. 2020 Feb 10;52(3):335-349.e7 - PubMed
- Gastroenterology. 2020 May;158(6):1698-1712.e14 - PubMed
- Annu Rev Cell Dev Biol. 2011;27:585-610 - PubMed
- Cell Cycle. 2019 Jun;18(12):1302-1315 - PubMed
- Cancer Cell. 2012 Jun 12;21(6):765-76 - PubMed
- Cold Spring Harb Perspect Biol. 2015 Feb 13;7(4):a015834 - PubMed
- Nat Commun. 2021 Jan 28;12(1):645 - PubMed
- J Biol Chem. 2003 May 23;278(21):19095-101 - PubMed
- Nat Rev Clin Oncol. 2018 Mar;15(3):139-150 - PubMed
- J Clin Invest. 2015 Mar 2;125(3):981-92 - PubMed
- Nat Cell Biol. 2012 Nov;14(11):1192-202 - PubMed
- Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3826-31 - PubMed
- Nature. 2010 Oct 7;467(7316):707-10 - PubMed
- Cancers (Basel). 2021 Oct 14;13(20): - PubMed
- Adv Exp Med Biol. 2010;676:123-35 - PubMed
- EMBO Rep. 2020 Dec 3;21(12):e50893 - PubMed
- Curr Biol. 2012 Jul 10;22(13):1166-75 - PubMed
- Mol Cell. 2015 Apr 2;58(1):147-56 - PubMed
- Nat Rev Gastroenterol Hepatol. 2020 Jul;17(7):391-405 - PubMed
- Nat Commun. 2021 Mar 25;12(1):1896 - PubMed
- Biomed Pharmacother. 2021 Aug;140:111731 - PubMed
- Hepatology. 2008 Nov;48(5):1655-64 - PubMed
- Curr Biol. 2014 Mar 17;24(6):598-608 - PubMed
- Nat Commun. 2021 Jan 28;12(1):646 - PubMed
- Semin Cell Dev Biol. 2013 Apr;24(4):347-56 - PubMed
- Curr Opin Cell Biol. 2018 Jun;52:136-144 - PubMed
- Proc Natl Acad Sci U S A. 1967 Feb;57(2):327-34 - PubMed
- Development. 2018 Jul 18;145(14): - PubMed
- Cell Stem Cell. 2020 Jan 2;26(1):34-47.e3 - PubMed
- Cancer Res. 2005 Jun 1;65(11):4568-77 - PubMed
Publication Types